PLYMOUTH
MEETING, Pa., March 26,
2024 /PRNewswire/ -- Harmony Biosciences Holdings,
Inc. (Nasdaq: HRMY), today announced that Harmony's management team
will participate in a fireside chat at the upcoming 23rd
Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024, at 9:30 a.m. ET.
A webcast of the fireside chat will be available on the investor
page of Harmony's website at
https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering
treatments for rare neurological diseases that others often
overlook. We believe that where empathy and innovation meet, a
better life can begin for people living with neurological diseases.
Established by Paragon Biosciences, LLC, in 2017 and headquartered
in Plymouth Meeting, PA, our team
of experts from a wide variety of disciplines and experiences is
driven by our shared conviction that innovative science translates
into therapeutic possibilities for our patients, who are at the
heart of everything we do. For more information, please visit
www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-23rd-annual-needham-virtual-healthcare-conference-302098733.html
SOURCE Harmony Biosciences